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Injections  of IgD  into  mice cause  an  enhancement  of the  primary  immune 
response to T-dependent antigens administered ~ 1 wk thereafter (1). In addition, 
the 7S antibody response to relatively T-independent antigens is augmented in 
mice bearing IgD-secreting myelomas (1). This enhancing effect is not obtained 
in athymic mice and we have suggested, therefore, that it might be mediated by 
T  cells.  In further studies we demonstrated that T  cells with receptors for IgD 
are induced by exposure to IgD either in vivo or in vitro (2). The kinetics of the 
appearance of these "T6" cells coincides with that of the in vivo enhancement of 
the immune response to trinitrophenylated hemocyanin (TNP-KLH),I suggesting 
that the T6 cells mediate the immunoenhancing effect. 
The results  to be presented  here  indicate  that  T  cells from  IgD-pretreated 
mice can  transfer the  IgD-induced  enhancement  of immune  responsiveness to 
normal recipients.  The presence of an increased incidence of Lyt-l+2  -  T6 cells 
in the donor cell population correlates with the ability of the cells to augment 
the immune response in recipients.  The data strongly suggest that T  cells with 
receptors  for  IgD  augment  immune  responses  in  an  antigen-dependent  but 
antigen-nonspecific manner. 
Materials and Methods 
Mice and Immunization.  BALB/c and CBA/J mice were obtained from Charles River 
Breeding Laboratories, Inc., Wilmington, MA.  TNP-conjugated KLH (Sigma Chemical 
Co., St. Louis, MO) was prepared as described by Little and Eisen (3). Mice were injected 
intravenously at 6-8 wks of age (day 0) with 100 ~g TNP-KLH. 
Plasmacytomas.  The IgD-secreting plasmacytoma, TEPC-1017, was maintained in vivo 
as previously described (1,  4).  Ascites fluid was examined for the presence of IgD by 
double diffusion in agar using goat anti-mouse IgD (I). Ascites fluid from mice bearing 
the  IgA-secreting  MOPC-167  plasmacytoma was  similarly collected.  Double  diffusion 
assays in agar confirmed the presence of IgA and the absence of detectable IgD in this 
ascites fluid. 
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l Abbreviations used in this paper."  C, complement; PBS, phosphate-buffered saline; PFC, plaque- 
forming cell; RFC, rosette-forming cell; SE, sheep erytbrocyte; TNP-KLH, trinitrophenylated he- 
mocyanin. 
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Purification of IgD.  TEPC-1017 ascites was passed over a column of rabbit anti-mouse 
lgD-coupled Sepharose 4B (Pharmacia Fine Chemicals, Piscataway, NJ). After extensive 
washing with phosphate-buffered saline (PBS), the IgD was eluted with 4.0 M MgCl~. The 
eluate was dialyzed and reconstituted to the same volume as the original ascites fluid. 
Spleen Cell Fractionation.  Adherent cells were removed by incubation of spleen cells 
in tissue culture grade petri dishes (1400-1; Nunclon, Roskilde, Denmark) at 37°C for 1 
h.  T  cells were eliminated by complement (C)-mediated cytolysis using a  monoclonal 
antibody to Thy-l.2 (6.80) provided by Dr. U.  Hammerling (Sloan-Kettering Institute, 
New York).  L3T4  ÷ cells were eliminated by treatment of spleen cells  with C  and the 
monoclonal antibody GK1.5 (5), provided by Dr. F.  Fitch, (University of Chicago, IL). 
Splenic T  cells were purified by negative selection with the use of goat anti-mouse Ig- 
coated petri dishes at 4°C as described (6). Lyt-l+2  -  T  cells were prepared from isolated 
T  cells by C-mediated cytolysis using the monoclonal antibody 19/178 (7) provided by 
Dr. U. Hammerling (Sloan-Kettering Institute). 
In some experiments, isolated T  cells were exposed to IgD- or IgA-containing ascites 
fluid using either TEPC-1017- or MOPC-167-coated petri dishes, respectively. Briefly, 
bacteriological grade,  100-ram petri dishes (Fisher Scientific Co., Pittsburgh, PA) were 
coated for 1 h at room temperature with  10 ml Tris buffer, pH 9.5, containing 6 mg of 
ascites protein from either the TEPC-1017 or MOPC-167  plasmacytoma. After three 
washes  with PBS containing 2% fetal calf serum, 3 x  107 T  cells suspended in 4 ml of 
PBS  were added  and  the  plates  were  further incubated at  37°C  for  1 h.  After this 
incubation procedure, cells were vigorously triturated to remove them from the dish and 
the harvested cells were washed three times with PBS. 
Cell Transfer.  Unless otherwise indicated,  107 spleen ceils, suspended in saline, were 
injected intravenously into recipients that had received 100 rad whole-body 3, irradiation 
1 d earlier from a 1~7Cs source (Isomedix, Inc., Parsippany, NJ). 
Plaque-forming Cell (PFC)  Assay.  Anti-TNP PFC were assayed by the slide modification 
of the technique ofJerne et al. (8). TNP sheep erythrocytes (SE) were prepared using the 
method described by Rittenberg and Pratt (9). IgG-producing cells were developed with 
rabbit anti-mouse Ig in the complement and goat anti-# in the agar (10).  Background 
anti-SE  PFC  were  routinely determined.  Mean  anti-SE  responses  in  all  control  and 
experimental groups were always <1,000 PFC/spleen. 
Rosette-forming Cell (RFC) Assay.  IgD-coated indicator cells were prepared by coupling 
affinity-purified IgD to SE using the CrCI3 coupling method of Poston (11). Coupling of 
IgD to SE was confirmed both by positive hemagglutination and indirect immunofluores- 
cence assays  using a  rabbit anti-mouse  IgD antiserum.  Enumeration of IgD-RFC  was 
performed as  previously described (2).  Lymphocytes surrounded  by more than  three 
indicator cells were scored as rosettes and the results expressed as percent RFC. In each 
experiment, the percentage of cells forming rosettes with SE was determined and was 
always <2%. 
Results 
Transfer of the Augmentation of the Response to TNP-KLH by T  Cells Exposed to 
IgD In Vivo.  The results in experiments I, 2, and 3 in Table I show that transfer 
of spleen  cells  from  IgD-pretreated  donors,  simultaneously  injected,  intrave- 
nously,  with  TNP-KLH,  led  to  enhanced  responses  in  3,-irradiated  (100  rad) 
recipients.  Similar results were obtained using unirradiated recipients (Table I, 
Exp. 4).  Normal spleen cells did not significantly raise the response above that 
of mice  receiving antigen  alone  (Exp.  1).  Spleen  cells,  depleted  of Ig-bearing 
cells  by  panning  on  anti-Ig-coated  petri  dishes,  transferred  the  IgD-induced 
augmentation  of the  immune  response,  whereas  anti-Thy-l.2  and  C-treated 
spleen cells from IgD-pretreated donors did not transfer augmentation (Exp. 2, 
Table I). Similarly, donor spleen cells from IgD-pretreated mice failed to transfer 1854  IMMUNOAUGMENTING  EFFECT  OF  T5  CELLS 
TABLE  I 
Ability of Splenic T Cells to Transfer the Immunoaugmenting Effect to IgD 
Donor cells 
transferred* 
Pre- 
injection 
of 
donors 
with 
IgD* 
Geometric mean (XSE) of anti-TNP PFC/spleen  ~ 
Exp.  1  Exp. 2  Exp. 3  Exp. 4 
None  2,230 (1.4)  2,480 (1.1)f,g  9,720 (1.1) 
Spleen cells  -  3,950 (1.3)a  ¢~  3,400 (1.4)b,c  9,840 (1.2)h 
+  12,320 (1.2)a  14,760 (1.1)b  6,950 (1.1)f  19,380 (l.1)h 
+1  11,060 (1.1)c 
Splenic T  cells  !  -  3,980 (1.2)d 
+  13,380 (1.2)d 
Splenic B cells**  -  3,840 (1.2)e 
+  4,370 (1.1)e 
L3T4- spleen cells**  +  3,240 (1.2)g 
* Recipients were irradiated on day -1  with  100 rad except in experiment 4. All recipients were 
injected intravenously on day 0 with 107 donor cells together with 100 #g TNP-KLH.  Anti-TNP 
PFC responses were determined on day 5 (n =  5-8). 
* Donor mice were preinjected intraperitoneally with 0.5 ml of IgD-containing ascites fluid on days 
-8, -7, -6, and -5 relative to the day of sacrifice (day 0). 
§ 
19S anti-TNP PFC responses, geometric mean _.X. SE. 
I T  cells were prepared by panning on anti-lg-coated dishes at 4°C after removal of adherent cells 
at 37 °C. Control cells were simultaneously incubated on uncoated dishes, 
Donors were injected intraperitoneally with 250 ttg affinity-purified IgD on days -8, -7, -6, and 
--5. 
** B cells were prepared by anti-Thy-l.2 +  C treatment; control cells were treated with C alone. 
** L3T4- spleen cells were prepared by cytotoxic elimination using GK1.5 +  C. 
H p  values: (a) 0.007, (b) 0.005, (c) 0.01, (d) 0.005, (e) not significant, (f) 0.05, (g) not significant, 
(h) 0.04. 
augmentation of the immune response when the L3T4 + T  cells were eliminated 
from the donor cell population (Table I, Exp. 3). These results together indicate 
that the augmentation  was mediated by L3T4 + T  cells. Transfer  of the helper 
T  cell subpopulation from IgD-pretreated donors showed that 5 x  106 Lyt-l+2  - 
cells caused as much augmentation  of the anti-TNP response as did  107 unfrac- 
tionated T  cells (Fig.  1). 
The incidence of IgD-RFC in these cell populations from IgD-pretreated mice 
was also determined  (Fig.  2).  The  background  IgD-RFC was <5%  for all  cell 
populations studied. Splenic B cells from IgD pretreated donors showed an IgD- 
RFC frequency barely above this  background.  We have  recently reported  (2) 
that L3T4- T  cells from IgD-pretreated mice also show only background levels 
of IgD-RFC. In contrast, both unfractionated and Lyt-l+2  - T  cells demonstrated 
a significantly increased percentage of IgD-RFC, ranging  from 20 to 30% (Fig. 
2). 
Transfer of the Augmentation  of the Response  to TNP-KLH by T  Cells Exposed  to 
IgD In Vitro.  In previous studies (2) it was shown that overnight incubation at 250 
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FIGURE  1.  Augmenting effect on the immune response by transfer of Lyt-l+2  - T cells from 
IgD-pretreated donors. Groups of five BALB/c recipient mice received 100 rad ~' irradiation 
on day -1. On day 0 they were injected intravenously with either 107 T cells or 5 x  106 Lyt- 
1+2  - T cells from ]gD-pretreated  or normal BALB/c mice, simultaneously with 100 t~g TNP- 
KLH. The augmenting  effect of cells from IgD-pretreated  as compared with normal donors 
was statistically significant: T cells, P -  0.01 (19S) and P = 0.002 (7S); Lyt-l÷2  - cells, P = 0.03 
(19S) and P = 0.01 (7S). 
37°C  of BALB/c  T  or  spleen  cells  with  IgD  induced  Lyt-l+2  -  T  cells  from 
normal  BALB/c mice to express detectable  IgD receptors.  It was of interest  to 
examine the kinetics of induction of IgD receptor-positive T  cells in vitro and to 
determine whether such T  cells could augment antibody formation in vivo. The 
results in Fig. 3 show that incubation for 1 h  in IgD-coated petri dishes, induced 
the appearance of IgD receptors on a  large percentage of T  cells, whereas cells 
incubated in IgA-coated or uncoated petri dishes did not. 
Whole  spleen  or  splenic  T  cells were  examined  for their  ability to augment 
immune responses in  100-rad-3,-irradiated  recipients after  1 h  preincubation  in 
vitro in petri dishes coated with IgD- or with IgA-containing ascites fluid or left 
uncoated  (Table  II). Cells from normal donors incubated  in  IgD-coated dishes 
enhanced  the immune response of recipients as compared with the responses of 
mice that received either antigen alone or antigen and cells incubated in uncoated 
dishes.  It should be noted that the TNP-KLH  preparation used in Exp. 2, Table 
II  induced  much  higher  responses  than  the  preparation  used  in  the  other 
experiments. However, the enhancement obtained with IgD-exposed T  cells was 
still  56%  for  19S  (P =  0.02) and  79% for 7S (P <  0.01) as compared with  37% 
for  19S (P =  0.02) and 0% for 7S with cells incubated on uncoated dishes.  Cells 
incubated  in  IgA-coated petri  dishes,  on  the  other  hand,  appeared  to  cause  a 
suppression of the immune response in recipients. To rule out the possibility that 
the  enhancement  by cells incubated  with  IgD was actually due  to the  injection 
of IgD which  leached off the dish during incubation,  thymocytes were similarly 
exposed  to  IgD-coated dishes  and  transferred.  The  responses  in  recipients  of 1856 
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FIGURE 3.  Incidence of lgD-RFC in BALB/c T  cells after incubation in dishes coated with 
IgD-containing ascites (TEPC- 1017), lgA-containing  ascites (MOPC- 167), or in uncoated petri 
dishes. The incubation period was  1 h at 37°C followed by the RFC assay as described in 
Materials and Methods. 
these cells were no  higher than  in recipients of antigen alone (data not shown). 
It was previously shown  (2) that  thymocytes cannot  be induced  to exhibit IgD- 
RFC by incubation with IgD. 
The response in recipients of IgD-pretreated  donor cells incubated in uncoated 
dishes (Exp.  1, Table II) was significantly higher than that in recipients of normal COICO  ET  AL.  1857 
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spleen cells similarly incubated (P =  0.003 for  19S and P  =  0.002 for 7S PFC). 
It was of interest to determine whether this immunoaugmenting effect of spleen 
cells that had already been exposed to IgD in vivo could still be enhanced further 
by reexposure to IgD in vitro. The results of Exps.  1 and 3, Table II show that 
this was indeed possible. The responses of recipients receiving ceils incubated in 
IgD-coated petri dishes (Exp.  1) showed a greater enhancement when cells from 
IgD-pretreated  donors rather  than  normal  cells were used (P --- 0.002  for  19S 
and P --- 0.035 for 7S PFC). Similarly, as shown in Exp. 3, Table II, when splenic 
T  cells isolated  from  IgD-pretreated  donors  were reexposed to  IgD  in  vitro, 
their  ability  to  enhance  the  response  in  recipients  was  further  enhanced  as 
compared  with  T  cells  incubated  either  on  uncoated  or  in  IgA-coated  petri 
dishes (P =  0.03 for 19S and P  =  0.01  for 7S PFC). 
Lack of Strain Specificity of the Effects of lgD.  In previous experiments (2) it was 
shown that IgD-RFC can be induced by exposure to IgD of a allotype in spleen 
ceils from b allotype congenic C.B20 mice. In addition, IgD-injected C.B20 mice 
showed significantly enhanced anti-TNP PFC responses (2).  It was of interest to 
determine whether exposure of T  cells from a mouse strain of different genetic 
background to TEPC-1017 protein had similar effects. Overnight incubation of 
CBA/J spleen cells at 37 °C in IgD-containing medium caused the appearance of 
29.4 +  1.9%  IgD-RFC (n =  9).  The results in Fig. 4  show, in addition,  that  T 
cells  from  normal  CBA/J  spleen  cells  incubated  in  IgD-coated  petri  dishes 
significantly enhanced both the 19S and 7S PFC responses to TNP-KLH of 100- 
rad 7-irradiated  syngeneic mice. 
Discussion 
The  present results establish  for the first time the existence of immunoaug- 
menting T  cells that are induced, either in vivo or in vitro, by exposure to IgD. 
Pretreatment of donors with IgD induced the appearance of a population of Lyt- 
1+2 -  T  cells  with  both  receptors  for  IgD  (T6)  and  the  ability  to  transfer 
augmentation  of the  immune  responses  to  lightly  irradiated  or  unirradiated 
recipients.  B cells from such IgD-pretreated  donors or spleen cells from which 
only the L3T4 + T  cells had been removed did not transfer immunoaugmentation 
and did not show increased rosette formation with IgD-coated SE. These results 
agree with our previous observation (2) that IgD-RFC induced by treatment with 
IgD in vivo are predominantly  L3T4 ÷, Lyt-1 +, Lyt-2-. In addition,  the kinetics 
of the appearance of these IgD-RFC after injection of IgD in vivo correlates with 
the enhancement of immune responses in IgD-injected mice (2). 
The augmenting effect of spleen cells incubated in IgD-coated petri dishes was 
probably not due to cotransfer of IgD, since the petri dishes had been extensively 
rinsed  to remove any weakly bound  IgD,  and  thymus cells incubated on  IgD- 
coated petri  dishes did not cause immunoaugmentation.  Previous experiments 
(2) have shown that  IgD-RFC can be induced  in spleen and lymph node cells, 
but not in thymus cells after in vivo or in vitro exposure to IgD. The observation 
that  IgD also induces immune-augmenting  properties and  IgD-RFC in T  cells 
from  CBA  mice,  indicates  that  these  effects  are  not  strain  specific.  This  is 
consistent with our previous finding (2) of augmentation of the immune response 400 
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FIGURE  4.  Augmenting effect on the immune response of splenic T  cells from CBA mice, 
after incubation  for  1 h  in TEPC-1017  ascites-coated petri dishes, in syngeneic,  100-rad ~,- 
irradiated recipients. The augmentation by T  cells exposed to IgD as compared with control 
cells, incubated in uncoated dishes, was statistically significant: P  --- 0.02 (19S) and P  =  0.008 
(7S). 
by  IgD  of a  allotype in  b  ailotype C.B20  mice,  indicating a  lack  of allotype 
specificity. 
Previous studies have shown that the injection of antigen (2) or allo anti-IgD 
(Coico,  unpublished results) induces the appearance of significantly increased 
numbers of IgD-RFC  (11  and  41%,  respectively) by  day  5  after injection  in 
BALB/c mice. It is possible that the augmentation of immune responses previ- 
ously shown to occur after injection of heterologous anti-IgD (12, 13) is, in part, 
the result of the induction of T6 cells, although an enhanced response to the 
foreign Ig bound to B cells, as shown by Finkeiman et al. (14), clearly plays an 
important part in this enhancement. It is probable that the augmenting effect of 
allotype-specific murine anti-IgD on the immune response to TNP-KLH of the 
alternate allotype in heterozygous mice (15) is due to induction of Tb cells. 
The  immunoaugmenting effect of two  injections  of  IgD  1  wk  apart  was 
previously shown to be greater than that of a  single IgD injection (2).  This is 
consistent with the present results showing that reexposure of T  cells from IgD- 
pretreated  mice  to  IgD  in  vitro  further  increases  their  immunoaugmenting 
capability. Since the frequency of IgD-RFC is already at maximal levels 7 d after 
a single injection of IgD, it seems possible that, as we suggested previously (2), 1860  IMMUNOAUGMENTING EFFECT OF  T5 CELLS 
the  reexposure  to  IgD  increases  the  avidity  of the T6  cells for  IgD either  by 
increasing the number of receptors or their affinity. 
IgD injection or transfer ofT6 cells did not cause an increase in the background 
PFC to SE. Thus,  the immunoaugmentation  appears to be antigen  dependent. 
We propose that the augmenting effect ofT6 cells is mediated by their interaction 
with surface IgD on B cells that are in the process of reacting with antigen, and 
not by recognition of IgD on the surface of resting B cells. These findings provide 
a  biological  rationale  for  the  presence  of IgD  on  the  B  cell  surface  and  its 
relatively  low  concentration  in  serum.  It  might  be  presumed  that,  after  its 
reaction with antigen, B cell surface IgD receives a signal from Ta cells. The T6 
cells may either  be induced  by increased serum  IgD levels, or possibly by IgD- 
antigen immune complexes in serum or on the B cell surface itself. It is interesting 
to note that both IgD-secreting myelomas (TEPC-I 017 and TEPC-1033) secrete 
IgD molecules which,  on  polyacrylamide gel electrophoresis,  appear  to be oli- 
gomers rather  than  monomers  (4).  Thus,  we are proposing the existence of a 
regulatory circuit based upon interaction between T6 cells, antigen, B cell surface 
IgD,  and  serum  IgD.  In addition,  the  possible role of passively acquired  IgD- 
antigen complexes on the T  cell surface in the induction of idiotype-antiidiotype 
circuits needs to be evaluated. 
Summary 
We  show  that  the  IgD-induced  augmentation  of the  immune  response  to 
trinitrophenylated  keyhole limpet hemocyanin can be transferred  to syngeneic 
mice  with  spleen  cells  from  IgD-injected  donors.  The  augmenting  activity  is 
present in the Lyt-l+2  -, L3T4 ÷ T  cell population and is absent from B cells. The 
ability of transferred  T  cells to augment  the  immune  response correlates  with 
the presence of a high frequency of Lyt-1 +2- T  cells that form rosettes with IgD- 
coated  sheep  erythrocytes  (T6  cells).  Such  rosette-forming  cells  can  also  be 
induced by incubation  of spleen ceils from normal  donors  in  IgD-coated petri 
dishes.  Injection  of  normal  spleen  cells  exposed  to  IgD-coated  petri  dishes 
together  with  antigen  also augments  the  immune  response  of recipients.  The 
existence  of a  regulatory  circuit  based  upon  interactions  between  T6  cells, 
antigen,  B cell surface IgD, and serum IgD, is proposed. 
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